Synopsis
The Biosimilar Work Sharing Initiative (BSWSI) builds on this success. The timelines for this will be dependent on the milestones for the review agreed by the participating regulators.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at MHRA (UK medicines regulator) ↗